Irvine, CA—BioCell Technology, LLC, announced the presentation of The Effects of Skin Aging Associated with the Use of BioCell Collagen in Healthy Adult Females: A Randomized, Double-blind, Placebo-controlled Clinical Trial. Results, according to a press release, were presented at the American Society for Nutrition 2019 on June 9.
The study was performed on 113 female subjects over the course of 12 weeks, during which participants were randomly assigned to either intervention or a placebo. The intervention consisted of twice-daily oral administration of 500mg BioCell Collagen, a supplement consisting of collagen type-II peptides, chondroitin sulfate, and hyaluronic acid.
The study found that supplementation, when compared to placebo, resulted in significantly reduced facial lines, crow’s feet, and wrinkles; increased skin elasticity and a 12% increase in cutaneous collagen content; and decreased skin dryness and erythema. The supplement was well tolerated, with no reported adverse reactions.
Suhail Ishaq, president of BioCell Technology, said in the release: “We are very excited to publish the findings of our largest study to date, which further supports the efficacy of our flagship dietary ingredient BioCell Collagen. Human clinical studies continue to be the gold standard for substantiating dietary supplement claims and we take pride that our licensed partners can take advantage.”